Profil
Tomas Leanderson is a Professor of Immunology at the University of Lund, where he has been employed since 1990.
He was previously the President, Co-Chief Executive Officer, and IR Contact at Active Biotech AB from 2008 to 2017.
He also served as a Director at ProNoxis AB. Leanderson earned a doctorate degree from Umea Universitet.
Postes actifs de Tomas Leanderson
| Sociétés | Poste | Début |
|---|---|---|
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 06/05/2010 |
Anciens postes connus de Tomas Leanderson
| Sociétés | Poste | Fin |
|---|---|---|
| ACTIVE BIOTECH AB | Directeur Général | 01/07/2017 |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Directeur/Membre du Conseil | - |
Formation de Tomas Leanderson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Active Biotech AB
Active Biotech AB BiotechnologyHealth Technology Develops drugs for cancer, neurodegenerative and inflammatory diseases | Health Technology |
University of Lund
University of Lund Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Umea Universitet
Umea Universitet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ProNoxis AB
ProNoxis AB Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs to treat chronic inflammation | Health Technology |
















